XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.20.2

Issued share capital, share premium account and share options | 12 Months Ended
--- | ---
Mar. 31, 2020
Issued share capital, share premium account and share options |
Issued share capital, share premium account and share options | 18. Issued share capital, share premium account and share options
| (a) |  | Share capital
|  | At March 31,
|  | 2020 |  | 2019 |  | 2018
|  | €M |  | €M |  | €M
Authorized/Share Capital reorganization |  |  |  |  |  |
1,550,000,000 ordinary equity shares of 0.600 euro cent each |  | 9.8 |  | 9.3 |  | 9.3
1,368,000,000 'B' Shares of 0.050 euro cent each |  | 0.7 |  | 0.7 |  | 0.7
1,368,000,000 Deferred shares of 0.050 euro cent each |  | 0.7 |  | 0.7 |  | 0.7
|  | 11.2 |  | 10.7 |  | 10.7
Allotted, called-up and fully paid: |  |  |  |  |  |
1,089,181,737 ordinary equity shares of 0.600 euro cent each |  | 6.5 |  | — |  | —
1,133,395,322 ordinary equity shares of 0.600 euro cent each |  | — |  | 6.8 |  | —
1,171,142,985 ordinary equity shares of 0.600 euro cent each |  | — |  | — |  | 7.0
Other movement in the share capital balance year-on-year principally relates to the cancellation of 47.2m shares relating to share buybacks (2019: 37.8m; 2018: 46.7m). There were 3m new shares issued in fiscal year 2020, following the exercise of vested share options, (2019: nil; 2018: nil). Ordinary equity shares do not confer on the holders thereof the specific right to be paid a dividend out of profits.
| (b) |  | Share premium account
|  | At March 31,
|  | 2020 |  | 2019 |  | 2018
|  | €M |  | €M |  | €M
Balance at beginning of year |  | 719.4 |  | 719.4 |  | 719.4
Issue of ordinary equity shares |  | 19.1 |  | — |  | —
Balance at end of year |  | 738.5 |  | 719.4 |  | 719.4
(c)Share options and share purchase arrangements Option Plan 2013 allows employees or Directors to purchase shares in the Company up to an aggregate of approximately 5% (when aggregated with other ordinary shares over which options are granted and which have not yet been exercised) of the outstanding ordinary shares of Ryanair Holdings plc, subject to certain conditions. All grants are subject to approval by the Remuneration Committee. These are exercisable at a price equal to the market price of the ordinary shares at the time options are granted. The key terms of these option plans include the requirement that certain employees remain in employment with the Company for a specified period of time and that the Company achieves certain net profit targets and/or share price targets. At the 2019 AGM, shareholders approved LTIP 2019. LTIP 2019 replaces Option Plan 2013 for all future share based payment grants. There were no grants under LTIP 2019 in fiscal year 2020. Details of the share options outstanding are set out below:
|  |  |  | Weighted
|  | Share Options |  | Average
|  | M |  | Exercise Price
Outstanding at March 31, 2017 |  | 20.1 |  | € | 7.70
Exercised |  | — |  | € | —
Granted |  | — |  | € | —
Forfeited |  | — |  | € | —
Outstanding at March 31, 2018 |  | 20.1 |  | € | 7.70
Granted |  | 20.0 |  | € | 11.12
Forfeited |  | (0.3) |  | € | 12.00
Outstanding at March 31, 2019 |  | 39.8 |  | € | 9.38
Granted |  | — |  | € | —
Forfeited |  | (2.0) |  | € | 12.47
Exercised |  | (3.0) |  | € | 6.31
Outstanding at March 31, 2020 |  | 34.8 |  | € | 9.57
The mid-market price of Ryanair Holdings plc’s ordinary shares on Euronext Dublin at March 31, 2020 was €9.33 (2019: €11.67; 2018: €16.00). The highest and lowest prices at which the Company’s shares traded on Euronext Dublin in fiscal year 2020 were €16.07 and €8.32 respectively (fiscal year 2019 were €16.72 and €10.04 respectively; fiscal year 2018 were €19.39 and €14.55 respectively). There were no options exercisable at March 31, 2020 (2019: nil; 2018: nil). The average share price for fiscal year 2020 was €11.77 (2019: €13.28; 2018: €16.95). There were 3m options exercised during fiscal years 2020 (2019: nil; 2018: nil). At March 31, 2020 the range of exercise prices and weighted average remaining contractual life of outstanding options are shown in the table below.
|  |  |  | No. |  | Remaining
|  | Exercise |  | options |  | contractual
|  | price |  | outstanding |  | life
|  | € |  | M |  | (years)
|  | 6.25 |  | 6.0 |  | 2.3
|  | 6.74 |  | 3.1 |  | 2.5
|  | 8.35 |  | 5.0 |  | 2.6
|  | 11.12 |  | 18.1 |  | 6.9
|  | 11.38 |  | 0.0 |  | 2.3
|  | 12.00 |  | 2.3 |  | 4.4
|  | 14.40 |  | 0.1 |  | 5.1
|  | 17.55 |  | 0.1 |  | 2.3
Weighted average |  | 9.57 |  | 34.8 |  | 4.9
The Company has accounted for its share option grants to employees at fair value, in accordance with IFRS 2, using a binomial lattice model to value the option grants. This has resulted in a charge of €7m to the income statement (2019: €8m; 2018: €6m charge) being recognized within the income statement in accordance with employee services rendered. A blend of the historical and implied volatilities of the Company’s own ordinary shares is used to determine expected volatility for share option granted. The weighted-average volatility is determined by calculating the weighted-average of volatilities for all share options granted in a given year. The expected term of share option grants represents the weighted-average period the awards are expected to remain outstanding. The service period is five years.

X
- Definition The entire disclosure for share capital, reserves and other equity interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 79 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_79&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition NA + References No definition available. + Details
Name: | ryaay_ShareCapitalSharePremiumAndShareOptionsAbstract
Namespace Prefix: | ryaay_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration